A wearable electrical nerve stimulation device can provide relief to people experiencing the persistent pain and fatigue linked to long COVID, a study co-led by UCLA and Baylor College of Medicine ...

Please provide your email address to receive an email when new articles are posted on . A study presented at this year’s virtual PAINWeek meeting further demonstrated the safety and efficacy of remote ...

RESEARCH TRIANGLE PARK – Durham-based Bioventus has received an OK from the U.S. Food and Drug Administration to market its next-generation pain treatment device. The global orthobiologics company has ...

A wearable electrical nerve stimulation device can provide relief to people experiencing the persistent pain and fatigue linked to long COVID, a study co-led by UCLA and Baylor College of Medicine ...

Using computer models and laboratory rats, Johns Hopkins researchers have demonstrated that Using computer models and laboratory rats, Johns Hopkins researchers have demonstrated that "direct ...

When a person moves, several different muscles in the back are used at the same time, making accurate diagnosis difficult. The detection device uses electric impulses to isolate each muscle. For more ...

Get the latest federal technology news delivered to your inbox. The Food and Drug Administration is set to publish a final rule in the Federal Register on Friday that would formally classify a new ...

Muscle pain can be a debilitating condition that affects your daily life, whether due to a sedentary lifestyle, overexertion, or chronic conditions. Many individuals search for practical solutions ...

When NeuroMetrix first unveiled the Quell a few years ago, its promise was a drug-free alternative using the body’s own mechanisms to combat chronic pain. Version 2.0 carries on with the same goal; ...

Chronic pain conditions, characterized by persistent or recurrent pain in specific parts of the body, can be highly debilitating and often significantly reduce the quality of life of the individuals ...

Nervomatrix, an Israeli pain-relief neurostimulation device company, received a $3.5 million investment and plans to create its North American headquarters in Akron, Ohio, according to a MedCity News ...